Thursday, May 7

Trump restores year-round Pell Grants in federal spending bill

President Donald Trump signed a federal spending bill into law May 5 that restores year-round Pell Grants. The grants will now cover summer sessions for university students, impacting nearly 80,000 University of California students, according to the UC Pell Grants fact sheet. Read more...

Photo: Congress approved a budget agreement that restores access to year-round Pell Grants and increases research funding. (Jintak Han/Assistant Photo editor)



UC Regents preview – May 16-18

The University of California Board of Regents, the governing board of the UC, will meet Tuesday through Thursday at UC San Francisco for its bimonthly meeting. Read more...

Photo: The governing board of the University of California will meet Tuesday through Thursday at UC San Francisco. The Board of Regents will vote on a nonresident student enrollment cap, discuss student housing and hear updates on the state budget, among other topics.(Mackenzie Possee/Assistant Photo editor)




Gov. Brown proposes holding funds for UC until audit suggestions are met

Gov. Jerry Brown proposed reserving $50 million for the University of California as part of the revised May budget he announced Thursday. Brown said he would hold the funds until the UC Office of the President implements recommendations that state auditor Elaine Howle made following her report. Read more...

Photo: Gov. Jerry Brown proposed reserving $50 million from the University of California until the Office of the President fully implements recommendations by the state auditor. (Daily Bruin file photo)


UCLA research helps expand use of drug to treat liver cancer

UCLA researchers helped test the first drug approved by the Food and Drug Administration to treat liver cancer in 10 years. They found through clinical trials that the drug, regorafenib, increased overall liver cancer patient survival period from a median of 7.8 months to 10.6 months. Read more...

Photo: The Food and Drug Administration approved the expansion of the use of regorafenib to treat advanced liver cancer April 27 with the help of a UCLA-led research. (Daily Bruin file photo)